The company CEO Albert Bourla said Pfizer has tapped two new contract manufacturers, and is also increasing the supply of raw materials from existing suppliers
Last month, the EU announced new requirements to force drug companies to obtain prior authorisation before sending shots manufactured in the EU to other countries